Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Oncology · Lancet Oncol · 2026-11-01
Guideline
Guo et al. Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology OrganisationsOncology · Lancet Oncol · 2026-11-01
RCTn = 160
Borchmann et al. Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 studyOncology · Lancet · 2026-10-26
RCTn = 299
Slomovitz et al. First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trialOncology · Lancet · 2026-10-26
RCTn = 498
Xu et al. Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in ChinaOncology · Lancet Oncol · 2026-10-25
RCTn = 231
Tao et al. Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trialOncology · Lancet · 2026-10-24
RCTn = 970
Sakakida et al. 14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in JapanOncology · N Engl J Med · 2026-10-15
RCTn = 236
Chiaretti et al. Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALLOncology · J Clin Oncol · 2026-10-12
RCTn = 898
Poppe et al. Randomized Trial of Hypofractionated Postmastectomy Radiation Therapy in Women With Breast Reconstruction (RT CHARM, Alliance A221505)Oncology · Lancet Oncol · 2026-10-09
RCTn = 98,755
Weigel et al. Invasive interval breast cancer rates after digital breast tomosynthesis plus synthesised mammography versus digital mammography screening (TOSYMA): 24-month follow-up of the multicentre, open-label, randomised, controlled, superiority trialOncology · J Clin Oncol · 2026-10-08
RCTn = 42
Chugh et al. RINGSIDE Phase II Study of Varegacestat for Treatment of Desmoid Tumors: A Randomized Dose-Finding Clinical TrialOncology · N Engl J Med · 2026-10-01
RCTn = 373
Mayer et al. Giredestrant plus Everolimus in Advanced Breast CancerOncology · Lancet Oncol · 2026-10-01
RCTn = 810
Sun et al. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer (CHN HYPOPMRT): 10-year outcomes from a randomised, non-inferiority, open-label, phase 3 trialOncology · Lancet Oncol · 2026-09-25
RCTn = 420
Lonial et al. Iberdomide plus daratumumab and dexamethasone versus daratumumab, bortezomib, and dexamethasone in patients with relapsed or refractory multiple myeloma (EXCALIBER-RRMM): an open-label, randomised, controlled, phase 3 trialOncology · J Clin Oncol · 2026-09-24
RCTn = 731
Peng et al. First-Line Retlirafusp Alfa Plus Chemotherapy for Human Epidermal Growth Factor Receptor 2-Negative Gastric or Gastroesophageal Junction Adenocarcinoma: A Randomized, Double-Blind, Phase III Study (RELIGHT)Oncology · J Clin Oncol · 2026-09-23
RCTn = 440
Ikeda et al. Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract CancerOncology · N Engl J Med · 2026-09-22
RCTn = 142,250
Sasieni et al. Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer DiagnosisOncology · N Engl J Med · 2026-09-17
RCTn = 709
Schrappe et al. Blinatumomab for Replacing Chemotherapy in Pediatric Acute Lymphoblastic LeukemiaOncology · N Engl J Med · 2026-09-17
RCTn = 10,799
Jover et al. Colonoscopy Intervals and Colorectal Cancer Incidence after Adenoma RemovalOncology · J Clin Oncol · 2026-09-16
Secondary analysisn = 587
Ma et al. Mindfulness and Tai Chi for Sleep, Fatigue, and Pain in Distressed People After Cancer Treatment: A Partially Randomized Patient-Preference Comparative Effectiveness TrialOncology · N Engl J Med · 2026-09-12
RCTn = 451
Zhao et al. Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy